Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
RecruitingNCT07060066Phase: NAStarted 2024-05-21
Summary
The purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia. Schizophrenia patients with d
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
60 Years
Locations
The University of Texas Health Science Center at HoustonHouston, Texas, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07060066